
CACI · NYSE
The supplied consensus is Buy across 14 analysts, with a mean target of $725; the evidence does not provide consensus low or high targets. Among specific targets cited, Citigroup’s $689 is the lowest and UBS’s $823 the highest, while Jefferies’ raised $725 target matches the supplied mean. UBS is therefore the most bullish named target; BNP Paribas is the most cautious by rating, downgrading to Underperform, though its target is not stated. The week’s cited revisions lean positive: Jefferies upgraded to Buy and raised its target, and Citigroup raised its target while maintaining Neutral. The disagreement centers on growth prospects versus program recompete exposure and the extent to which revenue growth converts into earnings.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Jefferies | — | $725 | +7.3% | Oct 26, 2026 | Open the report this row came from |